Botanical species · safety record

Gypsophila paniculata

The EFSA Compendium of Botanicals holds 8 constituent measurements and 2 adverse-effect records for Gypsophila paniculata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Gypsophila paniculata L.

8Constituent measurements

2Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Gypsogenin	Roots and other underground parts	Solvent extraction	≤ 0.34 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Gypsogenin	Roots and other underground parts	Solvent extraction	≥ 0.11 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Gypsogenin	Roots and other underground parts	Powder	0.52 Percent	HPLC with standard detection methods	Resolve DOI
Quillaic acid	Roots and other underground parts	Powder	0.3 Percent	HPLC with standard detection methods	Resolve DOI
Triterpene saponins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Saponins	Live plants	Solvent extraction	19 Percent	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Saponins	Live plants	—	—	—	No resolvable identifier
Triterpene saponins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Roots and other underground parts	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	—	—	—	In vitro	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Yao, Shun., Ma, Li., Luo, Jian-Guang., Wang, Jun-Song., Kong, Ling-Yi. New Triterpenoid Saponins from the Roots of Gypsophila paniculata L.. Helvetica chimica acta, 2010, vol. 93, no. 2, p. 361-374.
Yao Shun., Luo Jian-Guang., Ma Li., Kong Ling-Yi. Two New Triterpenoid Saponins from the Roots of Gypsophila paniculata with Potent alpha-Glucosidase Inhibition Activity . Chinese journal of natural medicines, 2011, vol. 9, no. 6, p. 401-405. DOI
Kolodziejski, I. Jozef., Stecka, Leokadia. Occurrence of saponins in various parts of Gypsophila paniculata and Gypsophila altissima. Farmacja polska, 1965, p. 751-754.
Vacek, Lubor., Sedlak, Bretislav. Comparison of physical, chemical, and biological properties of saponins. Gunma journal of medical sciences, 1962, p. 1-6.
Gevrenova, R., Joubert, O., Mandova, Tsv., Zaiou, M., Chapleur, Y., Henry, M. Cytotoxic effects of four Caryophyllaceae species extracts on macrophage cell lines . Pharmaceutical biology, 2014, vol. 52, no. 7, p. 919-925. DOI
Gevrenova, Reneta., Stancheva, Tanya., Voynikov, Yulian., Laurain-Mattar, Dominique., Henry, Max. Root in vitro cultures of six Gypsophila species and their saponin contents . Enzyme and microbial technology, 2010, vol. 47, no. 3, p. 97-104. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature